Skip to main content
Top
Published in: Rheumatology International 7/2012

01-07-2012 | Original Article

Association of Rsa polymorphism of the estrogen receptor-β gene with rheumatoid arthritis

Authors: Hiromi Sato, Ayano Ito, Aránzazu González-Canga, Hiroko Okuzawa, Kanako Ugai, Masahiko Suzuki, Takao Namiki, Koichi Ueno

Published in: Rheumatology International | Issue 7/2012

Login to get access

Abstract

To investigate the possible influence of the single nucleotide polymorphism (SNP) of the estrogen receptor-β gene, rs1256049 (Rsa) in exon 5, on the frequency of rheumatoid arthritis (RA), 263 RA patients and 174 control subjects with osteoarthritis (OA) were recruited. Rsa polymorphism was detected using a PCR–RFLP, Polymerase Chain Reaction—Restriction Fragment Length Polymorphism method. The occurrence of both mutant allele (G) and genotype (GG) were significantly higher in RA than in OA patients (allele P = 0.008, OR: 1.501, 95%CI: 1.12–2.02). In RA patients, GG genotype frequency was higher in severe RA patients than mild RA patients. Moreover, there was significant difference between severe RA patients and OA patients (P = 0.009), also the allele distribution was significant different between severe RA, mild RA, and OA patients (P = 0.025, 95%CI = 0.61–0.93). With respect to gender, GG genotype was statistically more frequent in female RA patients than that of OA, while such an association was not observed in men. Above all, the presence of the GG genotype could be a risk factor for RA and such trend might be different in gender, although additional larger scale study is needed.
Literature
1.
go back to reference Brooks PM (2006) Rheumatoid arthritis: aetiology and clinical features. Medicine 34:379–382CrossRef Brooks PM (2006) Rheumatoid arthritis: aetiology and clinical features. Medicine 34:379–382CrossRef
2.
3.
go back to reference Wordsworth P, Bell J (1991) Polygenic susceptibility in rheumatoid arthritis. Ann Rheum Dis 50:343–346PubMedCrossRef Wordsworth P, Bell J (1991) Polygenic susceptibility in rheumatoid arthritis. Ann Rheum Dis 50:343–346PubMedCrossRef
4.
go back to reference Combe B, Eliaou JF, Daures JP et al (1995) Prognostic factors in rheumatoid arthritis: comparative study of two subsets of patients according to severity of articular damage. Br J Rheumatol 34:529–534PubMedCrossRef Combe B, Eliaou JF, Daures JP et al (1995) Prognostic factors in rheumatoid arthritis: comparative study of two subsets of patients according to severity of articular damage. Br J Rheumatol 34:529–534PubMedCrossRef
6.
go back to reference Wolfe F (1997) The prognosis of rheumatoid arthritis: assessment of disease activity and disease severity in the clinic. Am J Med 103:12S–18SPubMedCrossRef Wolfe F (1997) The prognosis of rheumatoid arthritis: assessment of disease activity and disease severity in the clinic. Am J Med 103:12S–18SPubMedCrossRef
7.
go back to reference Nelson JL, Ostensen M (1997) Pregnancy and rheumatoid arthritis. Rheum Dis Clin North Am 23:195–212PubMedCrossRef Nelson JL, Ostensen M (1997) Pregnancy and rheumatoid arthritis. Rheum Dis Clin North Am 23:195–212PubMedCrossRef
8.
go back to reference Kuiper S, van Gestel AM, Swinkels HL et al (2001) Influence of sex, age, and menopausal state on the course of early rheumatoid arthritis. J Rheumatol 28:1809–1816PubMed Kuiper S, van Gestel AM, Swinkels HL et al (2001) Influence of sex, age, and menopausal state on the course of early rheumatoid arthritis. J Rheumatol 28:1809–1816PubMed
9.
go back to reference Tengstrand B, Ahlmén M, Hafström I (2004) The influence of sex on rheumatoid arthritis: a prospective study of onset and outcome after 2 years. J Rheumatol 31:214–222PubMed Tengstrand B, Ahlmén M, Hafström I (2004) The influence of sex on rheumatoid arthritis: a prospective study of onset and outcome after 2 years. J Rheumatol 31:214–222PubMed
10.
go back to reference Hall GM, Daniels M, Huskisson EC, Spector TDA (1994) Randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis. Ann Rheum Dis 53:112–116PubMedCrossRef Hall GM, Daniels M, Huskisson EC, Spector TDA (1994) Randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis. Ann Rheum Dis 53:112–116PubMedCrossRef
11.
go back to reference Silman AJ, Pearson JE (2002) Epidemiology and genetics of rheumatoid arthritis. Arthritis Res 4:S265–S272PubMedCrossRef Silman AJ, Pearson JE (2002) Epidemiology and genetics of rheumatoid arthritis. Arthritis Res 4:S265–S272PubMedCrossRef
12.
go back to reference Brennan P, Bankhead C, Silman A, Symmons D (1997) Oral contraceptives and rheumatoid arthritis: results from a primary care-based incident case-control study. Semin Arthritis Rheum 26:817–823PubMedCrossRef Brennan P, Bankhead C, Silman A, Symmons D (1997) Oral contraceptives and rheumatoid arthritis: results from a primary care-based incident case-control study. Semin Arthritis Rheum 26:817–823PubMedCrossRef
13.
go back to reference Weitzmann MN, Pacifici R (2006) Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest 116:1186–1194PubMedCrossRef Weitzmann MN, Pacifici R (2006) Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest 116:1186–1194PubMedCrossRef
14.
go back to reference Kuiper GG, Enmark E, Pelto-Huikko M et al (1996) Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925–5930PubMedCrossRef Kuiper GG, Enmark E, Pelto-Huikko M et al (1996) Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925–5930PubMedCrossRef
15.
go back to reference Mosselman S, Polman J, Dijkema R (1996) ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 392:49–53PubMedCrossRef Mosselman S, Polman J, Dijkema R (1996) ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 392:49–53PubMedCrossRef
16.
go back to reference Forsell C, Enmark E, Axelman K et al (2001) Investigations of a CA repeat in the oestrogen receptor beta gene in patients with Alzheimer’s disease. Eur J Hum Genet 9:802–804PubMedCrossRef Forsell C, Enmark E, Axelman K et al (2001) Investigations of a CA repeat in the oestrogen receptor beta gene in patients with Alzheimer’s disease. Eur J Hum Genet 9:802–804PubMedCrossRef
17.
go back to reference Sano M, Inoue S, Hosoi T et al (1995) Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. Biochem Biophys Res Commun 217:378–383PubMedCrossRef Sano M, Inoue S, Hosoi T et al (1995) Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. Biochem Biophys Res Commun 217:378–383PubMedCrossRef
18.
go back to reference Nilsson M, Naessen S, Dahlman I (2004) Association of estrogen receptor beta gene polymorphisms with bulimic disease in women. Mol Psychiatry 9:28–34PubMedCrossRef Nilsson M, Naessen S, Dahlman I (2004) Association of estrogen receptor beta gene polymorphisms with bulimic disease in women. Mol Psychiatry 9:28–34PubMedCrossRef
19.
go back to reference Wang Z, Yoshida S, Negoro K et al (2004) Polymorphisms in the estrogen receptor beta gene but not estrogen receptor alpha gene affect the risk of developing endometriosis in a Japanese population. Fertil Steril 81:1650–1656PubMedCrossRef Wang Z, Yoshida S, Negoro K et al (2004) Polymorphisms in the estrogen receptor beta gene but not estrogen receptor alpha gene affect the risk of developing endometriosis in a Japanese population. Fertil Steril 81:1650–1656PubMedCrossRef
20.
go back to reference Sundarrajan C, Liao WX, Roy AC, Ng SC (2001) Association between estrogen receptor-beta gene polymorphisms and ovulatory dysfunctions in patients with menstrual disorders. J Clin Endocrinol Metab 86:135–139PubMedCrossRef Sundarrajan C, Liao WX, Roy AC, Ng SC (2001) Association between estrogen receptor-beta gene polymorphisms and ovulatory dysfunctions in patients with menstrual disorders. J Clin Endocrinol Metab 86:135–139PubMedCrossRef
21.
go back to reference González-Canga A, Ugai K, Okuzawa H et al (2010) Association of cytosin-adenine repeat polymorphism of the estrogen reseptor-β gene withrheumatoid arthritis symptoms. Rheumatol Int 30:1259–1262PubMedCrossRef González-Canga A, Ugai K, Okuzawa H et al (2010) Association of cytosin-adenine repeat polymorphism of the estrogen reseptor-β gene withrheumatoid arthritis symptoms. Rheumatol Int 30:1259–1262PubMedCrossRef
22.
go back to reference Rexrode K, Ridker P, Hegener H et al (2007) Polymorphisms and haplotypes of the estrogen receptor-beta gene (ESR2) and cardiovascular disease in men and women. Clin Chem 53:1749–1756PubMedCrossRef Rexrode K, Ridker P, Hegener H et al (2007) Polymorphisms and haplotypes of the estrogen receptor-beta gene (ESR2) and cardiovascular disease in men and women. Clin Chem 53:1749–1756PubMedCrossRef
23.
go back to reference Setiawan VW, Hankinson SE, Colditz GA et al (2004) Estrogen receptor beta (ESR2) polymorphisms and endometrial cancer (United States). Cancer Causes Control 15:627–633PubMedCrossRef Setiawan VW, Hankinson SE, Colditz GA et al (2004) Estrogen receptor beta (ESR2) polymorphisms and endometrial cancer (United States). Cancer Causes Control 15:627–633PubMedCrossRef
24.
go back to reference Ochi T, Iwase R, Yonemasu K et al (1988) Natural course of joint destruction and fluctuation of serum C1q levels in patients with rheumatoid arthritis. Arthritis Rheum 31:37–43PubMedCrossRef Ochi T, Iwase R, Yonemasu K et al (1988) Natural course of joint destruction and fluctuation of serum C1q levels in patients with rheumatoid arthritis. Arthritis Rheum 31:37–43PubMedCrossRef
26.
go back to reference Karlson EW, Chibnik LB, McGrath M et al. (2009) A prospective study of androgen levels, hormone-related genes and risk of rheumatoid arthritis. Arthritis Res Ther 11:R97 Karlson EW, Chibnik LB, McGrath M et al. (2009) A prospective study of androgen levels, hormone-related genes and risk of rheumatoid arthritis. Arthritis Res Ther 11:R97
28.
go back to reference Arko B, Prezelj J, Komel R et al (2002) No major effect of estrogen receptor beta gene RsaI polymorphism on bone mineral density and response to alendronate therapy in postmenopausal osteoporosis. J Steroid Biochem Mol Biol 81:147–152PubMedCrossRef Arko B, Prezelj J, Komel R et al (2002) No major effect of estrogen receptor beta gene RsaI polymorphism on bone mineral density and response to alendronate therapy in postmenopausal osteoporosis. J Steroid Biochem Mol Biol 81:147–152PubMedCrossRef
29.
go back to reference Welcome Trust Case Control Consortium (2007) Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 447:661–678CrossRef Welcome Trust Case Control Consortium (2007) Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 447:661–678CrossRef
30.
go back to reference Youn J, Kim H, Park J et al (2002) Regulation of TNF-alpha-mediated hyperplasia through TNF receptors, TRAFs, and NF-kappaB in synoviocytes obtained from patients with rheumatoid arthritis. Immunol Lett 83:85–93PubMedCrossRef Youn J, Kim H, Park J et al (2002) Regulation of TNF-alpha-mediated hyperplasia through TNF receptors, TRAFs, and NF-kappaB in synoviocytes obtained from patients with rheumatoid arthritis. Immunol Lett 83:85–93PubMedCrossRef
31.
go back to reference Harris HA, Albert LM, Leathurby Y et al (2003) Evaluation of an estrogen receptor-beta agonist in animal models of human disease. Endocrinology 144:4241–4249PubMedCrossRef Harris HA, Albert LM, Leathurby Y et al (2003) Evaluation of an estrogen receptor-beta agonist in animal models of human disease. Endocrinology 144:4241–4249PubMedCrossRef
32.
go back to reference Cvoro A, Tatomer D, Tee MK et al (2008) Selective estrogen receptor-beta agonist repress transcription of proinflamattory genes. J Immunol 180:630–636PubMed Cvoro A, Tatomer D, Tee MK et al (2008) Selective estrogen receptor-beta agonist repress transcription of proinflamattory genes. J Immunol 180:630–636PubMed
33.
go back to reference Harris HA (2007) Estrogen receptor-beta: recent lessons from in vivo studies. Mol Endocrinol 21:1–13PubMedCrossRef Harris HA (2007) Estrogen receptor-beta: recent lessons from in vivo studies. Mol Endocrinol 21:1–13PubMedCrossRef
34.
go back to reference Follettie MT, Pinard M, Keith JC et al (2006) Organ messenger ribonucleic acid and plasma proteome changes in the adjuvant-induced arthritis model: responses to disease induction and therapy with the estrogen receptor-beta selective agonist ERB-041. Endocrinology 147:714–723PubMedCrossRef Follettie MT, Pinard M, Keith JC et al (2006) Organ messenger ribonucleic acid and plasma proteome changes in the adjuvant-induced arthritis model: responses to disease induction and therapy with the estrogen receptor-beta selective agonist ERB-041. Endocrinology 147:714–723PubMedCrossRef
35.
go back to reference Engdahl C, Jochems C, Windahl SH et al (2010) Amelioration of collagen-induced arthritis and immune-associated bone loss through signaling via estrogen receptor alpha, and not estrogen receptor beta or G protein-coupled receptor 30. Arthritis Rheum 62:524–533PubMed Engdahl C, Jochems C, Windahl SH et al (2010) Amelioration of collagen-induced arthritis and immune-associated bone loss through signaling via estrogen receptor alpha, and not estrogen receptor beta or G protein-coupled receptor 30. Arthritis Rheum 62:524–533PubMed
Metadata
Title
Association of Rsa polymorphism of the estrogen receptor-β gene with rheumatoid arthritis
Authors
Hiromi Sato
Ayano Ito
Aránzazu González-Canga
Hiroko Okuzawa
Kanako Ugai
Masahiko Suzuki
Takao Namiki
Koichi Ueno
Publication date
01-07-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 7/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-1947-2

Other articles of this Issue 7/2012

Rheumatology International 7/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.